REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/15/2026
Back to search
Official data from USPTO
MESOTHELIOMA PROGNOSIS NETWORK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MESOTHELIOMA PROGNOSIS NETWORK
ST13
US500000087086343Class
35, 36, 44, 45
Filing
87086343
Registration
5143687
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
02/16/2026
Trademark type
Word
Nice classes
35, 36, 44, 45
Filing date
06/28/2016
Registration date
02/14/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/12/2023
Last transaction
02/16/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
First use anywhere
10/18/2014
First use in commerce
10/18/2014
Drawing code
4
Owner type
16
Owner location
Newark, DE
Examiner
SPARACINO, MARK V
Law office
L30
Current location
TMEG LAW OFFICE 103
Holders and representatives
Holders
Mesothelioma Prognosis Network, LLC
Representatives
Brian S. Steinberger LAW OFFICES OF BRIAN S. STEINBERGER, P.A.
Technical classification
Nice Classes
Class 35Class 36Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting public interest and awareness of individuals suffering from or affected by asbestos related cancers and diseases
Class 36
Providing information on financial assistance sources for patients for treatment of asbestos related cancers and diseases; providing financial informationproviding links to the websites of others featuring information about financial assistance sources for patients for treatment of asbestos related cancers and diseases
Class 44
Providing a website featuring medical information about asbestos related cancers and diseases treatment options; providing links to the websites of others featuring information about the diagnosis and treatment of asbestos related cancers and diseases
Class 45
Providing patient advocate services in the field of asbestos related cancers and disease treatment; providing patient and family support of patients with asbestos related cancers and diseasesemotional counseling and emotional support
Publications
History of USPTO decisions and trademark events.
25 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
04/12/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
04/12/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/12/2023
ES8R
TEAS SECTION 8 RECEIVED
09/01/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/14/2022
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
02/14/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/09/2017
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2016
ALIE
ASSIGNED TO LIE
12/07/2016
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/17/2016
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/14/2016
GNFR
FINAL REFUSAL E-MAILED
11/14/2016
CNFR
FINAL REFUSAL WRITTEN
11/14/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/28/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/28/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/28/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/07/2016
GNRT
NON-FINAL ACTION E-MAILED
10/07/2016
CNRT
NON-FINAL ACTION WRITTEN
10/07/2016
DOCK
ASSIGNED TO EXAMINER
10/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2016
NWAP
NEW APPLICATION ENTERED
07/01/2016
Continuous trademark protection
Get notified about every new filing that threatens MESOTHELIOMA PROGNOSIS NETWORK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.